ARTLVSNIVF• 12 Months (Normalized)
ARTL vs NIVF (Artelo Biosciences Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-96.34%
Artelo Biosciences Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
+%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin NIVF LEADS
-96.34 pts
NIVF outperforming by 96.34 percentage points
ARTLNIVF
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | ARTL Price | ARTL Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -96.34% | $- | - | |
| Sep 24, 2026 | $5.17 | -95.83% | $- | - | |
| Sep 23, 2026 | $7.31 | -94.10% | $0.59 | -99.94% | +5.84% |
| Sep 22, 2026 | $4.15 | -96.65% | $0.73 | -99.92% | +3.27% |
| Sep 21, 2026 | $4.10 | -96.69% | $0.72 | -99.93% | +3.24% |
| Sep 18, 2026 | $3.94 | -96.82% | $0.72 | -99.93% | +3.11% |
| Sep 17, 2026 | $3.97 | -96.80% | $0.72 | -99.93% | +3.13% |
| Sep 16, 2026 | $3.75 | -96.97% | $0.79 | -99.92% | +2.95% |
| Sep 15, 2026 | $5.34 | -95.69% | $0.84 | -99.91% | +4.22% |
| Sep 14, 2026 | $4.87 | -96.07% | $0.93 | -99.90% | +3.83% |
| Sep 11, 2026 | $5.43 | -95.62% | $1.06 | -99.89% | +4.27% |
| Sep 10, 2026 | $5.63 | -95.46% | $1.11 | -99.89% | +4.43% |
| Sep 09, 2026 | $5.98 | -95.17% | $1.10 | -99.89% | +4.72% |
| Sep 08, 2026 | $6.19 | -95.01% | $1.11 | -99.89% | +4.88% |
| Sep 04, 2026 | $6.04 | -95.13% | $1.14 | -99.88% | +4.75% |
Page 1 of 17